Advances CytoSorb as a Potentially Revolutionary Therapeutic Advance to Reverse Deadly Shock in Critically Ill and Cardiac Surgery PatientsPRINCETON, N.J., Aug. 31, 2023 CytoSorbents Corporation.
PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) CytoSorbents Corporation (NASDAQ:CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Is it Time for a Change in How Structural MRI Data is Collected?
New study shows there is a lot to consider
T1 structural images for the two sequences, MPRAGE and MPRAGE+PMC. The top row shows the MPRAGE sequence, while the bottom row shows the images that were generated with the MPRAGE+PMC sequence. Columns represent two different participants, one with minimal head motion (left, Low-Mover) and another with a large quantity of motion (right, High-Mover). Pial and white matter (WM) surface reconstruction from Freesurfer are also shown.
February 17, 2021 A new paper, Is it time to switch your T1W sequence? Assessing the impact of prospective motion correction on the reliability and quality of structural imaging, evaluates two different ways of collecting magnetic resonance imaging (MRI) structural images. The first type of sequence, called MPRAGE, has been widely used by the neuroimaging research community for the last 20-plus years. More recently, an updated version of this